Literature DB >> 18624916

NCAM-derived peptides function as agonists for the fibroblast growth factor receptor.

Stine M M Hansen1, Lene B Køhler, Shizhong Li, Vladislav Kiselyov, Claus Christensen, Sylwia Owczarek, Elisabeth Bock, Vladimir Berezin.   

Abstract

The neural cell adhesion molecule (NCAM) directly interacts with the fibroblast growth factor receptor (FGFR). Both fibronectin type III (FN3) modules of NCAM are involved in this interaction. One of the NCAM-FGFR contact sites has been localized recently to the upper N-terminal part of the second NCAM FN3 module encompassing the F and G beta-strands and the interconnecting loop region. Here, we investigated whether any of the six putative strand-loop-strand regions in the first NCAM FN3 module are involved in FGFR interactions. Peptide sequences encompassing these regions, termed encamins, were synthesized and tested for their ability to bind and activate FGFR. Encamins localized to the N-terminal part of the first FN3 module did not interact with FGFR, whereas encamins localized to the C-terminal part, termed EncaminA, C and E, bound to and activated FGFR. The encamins induced FGFR-dependent neurite outgrowth, and EncaminC and E promoted neuronal survival and enhanced pre-synaptic function. In conclusion, the interaction between NCAM and FGFR probably involves multiple contact sites at an interface formed by the two NCAM FN3 modules and FGFR, and encamins could constitute important pharmacological tools for the study of specific functional aspects of NCAM, including neuroprotection and modulation of plasticity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624916     DOI: 10.1111/j.1471-4159.2008.05544.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  NCAM function in the adult brain: lessons from mimetic peptides and therapeutic potential.

Authors:  Glenn Dallérac; Claire Rampon; Valérie Doyère
Journal:  Neurochem Res       Date:  2013-03-14       Impact factor: 3.996

2.  Screening of bioactive peptides using an embryonic stem cell-based neurodifferentiation assay.

Authors:  Ruodan Xu; Maxime Feyeux; Stéphanie Julien; Csilla Nemes; Morten Albrechtsen; Andras Dinnyés; Karl-Heinz Krause
Journal:  AAPS J       Date:  2014-02-21       Impact factor: 4.009

3.  Identification of novel peptoid agonists of fibroblast growth factor receptor using microarray-based screening.

Authors:  Junjie Fu; Amy Xia; Xin Qi
Journal:  Medchemcomm       Date:  2016-04-14       Impact factor: 3.597

Review 4.  NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders.

Authors:  Chengyan Chu; Yue Gao; Xiaoyan Lan; Aline Thomas; Shen Li
Journal:  Neurochem Res       Date:  2018-07-12       Impact factor: 3.996

5.  Portrait of an enzyme, a complete structural analysis of a multimodular {beta}-N-acetylglucosaminidase from Clostridium perfringens.

Authors:  Elizabeth Ficko-Blean; Katie J Gregg; Jarrett J Adams; Jan-Hendrik Hehemann; Mirjam Czjzek; Steven P Smith; Alisdair B Boraston
Journal:  J Biol Chem       Date:  2009-02-04       Impact factor: 5.157

Review 6.  Neuritogenic and neuroprotective properties of peptide agonists of the fibroblast growth factor receptor.

Authors:  Shizhong Li; Elisabeth Bock; Vladimir Berezin
Journal:  Int J Mol Sci       Date:  2010-05-26       Impact factor: 5.923

7.  The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling.

Authors:  Silvia Zecchini; Lorenzo Bombardelli; Alessandra Decio; Marco Bianchi; Giovanni Mazzarol; Fabio Sanguineti; Giovanni Aletti; Luigi Maddaluno; Vladimir Berezin; Elisabeth Bock; Chiara Casadio; Giuseppe Viale; Nicoletta Colombo; Raffaella Giavazzi; Ugo Cavallaro
Journal:  EMBO Mol Med       Date:  2011-07-08       Impact factor: 12.137

8.  Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.

Authors:  Marco Rusnati; Antonella Bugatti; Stefania Mitola; Daria Leali; Paolo Bergese; Laura E Depero; Marco Presta
Journal:  Sensors (Basel)       Date:  2009-08-20       Impact factor: 3.576

9.  Neuroprotective role of fibronectin in neuron-glial extrasynaptic transmission.

Authors:  Jintang Wang; Ling Yin; Zheng Chen
Journal:  Neural Regen Res       Date:  2013-02-05       Impact factor: 5.135

10.  NCAM2 Fibronectin type-III domains form a rigid structure that binds and activates the Fibroblast Growth Factor Receptor.

Authors:  Kim Krighaar Rasmussen; Maria Hansen Falkesgaard; Malene Winther; Nikolaj Kulahin Roed; Christine Louise Quistgaard; Marie Nygaard Teisen; Sofie Marie Edslev; David Leander Petersen; Ali Aljubouri; Claus Christensen; Peter Waaben Thulstrup; Leila Lo Leggio; Kaare Teilum; Peter Schledermann Walmod
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.